FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267)

NCT01065779 · clinicaltrials.gov ↗

COMPLETED

Status

880

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: FOSAMAX PLUS
DRUG: FOSAMAX PLUS D

Sponsor

Organon and Co